C - Chemistry – Metallurgy – 07 – J
Patent
C - Chemistry, Metallurgy
07
J
C07J 73/00 (2006.01) A61K 31/58 (2006.01) C07C 235/82 (2006.01) C07J 3/00 (2006.01) C07J 41/00 (2006.01)
Patent
CA 2170047
The present invention relates to the compound of formula (I), also known as 17.beta.-N-(2,5- bis(Trifluoromethyl))phenylcarbamoyl-4.-aza-5.alpha.-androst-1- en-3-one, solvates thereof, its preparation, intermediates used in its preparation, pharmaceutical formulations thereof and its use in the treatment of androgen responsive and mediated diseases.
La présente invention a pour objet le composé selon la formule (I), également connu sous le nom de 17 beta -N-(2,5-bis(trifluorométhyl))phénylcarbamoyl-4-aza-5 alpha -androst-1-en-3-one, des solvates de celui-ci, sa préparation, des intermédiaires utilisés pour celle-ci, des formulations pharmaceutiques de ce composé et son utilisation dans le traitement des maladies répondant aux androgènes ou à médiation par les androgènes.
Batchelor Kenneth William
Frye Stephen Vernon
Fetherstonhaugh & Co.
Glaxo Wellcome Inc.
LandOfFree
Androstenone derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Androstenone derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Androstenone derivative will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1486422